Mangoceuticals, Inc.
Market Cap
$4.57M
P/E Ratio
-0.14
EPS
$-2.95
Dividend Yield
0.00%
52-Week Range
$0.33 — $5.20
Volume
4.00M
Avg Volume
7.65M
Beta
2.33
P/E (TTM)
-0.14
Forward P/E
—
PEG Ratio
-0.02
P/S (TTM)
9.39
P/B (TTM)
0.28
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-1.15%
ROA (TTM)
-1.20%
ROIC
—
Gross Margin
0.61%
Operating Margin
-41.43%
Net Margin
—
Debt/Equity
0.01
Current Ratio
0.74
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-33.42%
EPS Growth (5Y)
-25.07%
Sales Growth (3Y)
+26.89%
Sales Growth (5Y)
+20.17%
EPS Est (This Year)
—
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.04
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
11.44M
Float
5.55M
Free Float %
48.56%
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
US
Exchange
NASDAQ
IPO Date
2023-03-21
Employees
3
CEO
Jacob D. Cohen
Index Membership
—
Website
https://www.mangorx.com
Mangoceuticals, Inc. (MGRX) is a healthcare company in the medical - healthcare information services industry listed on the NASDAQ. With a market capitalization of $4.57M, a P/E ratio of -0.14, MGRX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare MGRX against other stocks using dozens of fundamental and technical filters.
Mangoceuticals, Inc. (MGRX) has a trailing twelve-month (TTM) P/E ratio of -0.14. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Mangoceuticals, Inc. (MGRX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Mangoceuticals, Inc. (MGRX) has a market capitalization of $4.57 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.